From: Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors
Parameter
Number
Sex
Male
39
Female
28
Binet stage at diagnosis
A
54
B
7
C
2
CD38 expression
Positive
23
Negative
4
Surface Ig expression
MD
48
G
16
IGHV gene mutational status
Mutated
44
Unmutated
Disease progression
Progressive
25
Stable
3